Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Ein echter Gamechanger: Diese News kann den Grundstein für eine Neubewertung der Rock-Tech-Aktie legen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40758 | ISIN: US98944F1093 | Ticker-Symbol:
NASDAQ
26.06.25 | 17:00
3,100 US-Dollar
0,00 % 0,000
1-Jahres-Chart
ZEO ENERGY CORPORATION Chart 1 Jahr
5-Tage-Chart
ZEO ENERGY CORPORATION 5-Tage-Chart

Aktueller Chart ZEO ENERGY Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
ZEO ENERGY CORPORATION-Investoren interessieren sich auch für diese Wertpapiere
Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial ResultsRevenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024EBITDA loss improved...
► Artikel lesen
Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy ChainBOULDER, CO / ACCESS Newswire / April 22, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...
► Artikel lesen
Pre-market Movers: 2seventy bio, Sonoma Pharmaceuticals, Tenon Medical, Arvinas, NET Power Inc.LONDON (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 09.00 A.M. ET).In the Green 2seventy bio, Inc. (TSVT) is up over 76% at $4.93. Sonoma...
► Artikel lesen
Metavista3D Inc.: Metavista Announces Filing of Annual and Interim Financial Statements and Revocation of MCTOVANCOUVER, BC / ACCESS Newswire / June 23, 2025 / Metavista3D Inc. (TSXV:DDD)(FSE:E3T) ("Metavista3D" or the "Company") today announced that effective June 23, 2025, the British Columbia Securities...
► Artikel lesen
Metavista3D Inc.: Metavista Provides Disclosure ClarificationsVANCOUVER, BC / ACCESS Newswire / June 13, 2025 / Metavista3D Inc. (TSXV:DDD)(FSE:E3T) ("Metavista3D" or the "Company") announces that, as a result of a continuous disclosure review by the British Columbia...
► Artikel lesen
Metavista3D Inc.: Metavista Provides Second Bi-weekly MCTO Status UpdateVANCOUVER, BC / ACCESS Newswire / May 30, 2025 / Metavista3D Inc. (TSXV:DDD)(FSE:E3T) ("Metavista3D" or the "Company") is providing this bi-weekly default status report in accordance with National Policy...
► Artikel lesen
Acadia Pharmaceuticals Inc.: Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 StudyAcadia Pharmaceuticals Inc. (Nasdaq: ACAD) and Saniona (OMX: SANION) today announced the successful completion of the two originally planned cohorts in their Phase 1 multiple-ascending-dose MAD study...
► Artikel lesen
Acadia Pharmaceuticals Inc.: Acadia Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Trofinetide for the Treatment of Rett Syndrome -- Filing marks company's first Marketing Authorization Application in Europe Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the company has submitted a Marketing Authorization...
► Artikel lesen
S&P Dow Jones Indices: Acadia Pharmaceuticals Set to Join S&P SmallCap 600NEW YORK, Dec. 30, 2024 /PRNewswire/ -- Acadia Pharmaceuticals Inc. (NASD: ACAD) will replace Independent Bank Group Inc. (NASD: IBTX) in the S&P SmallCap 600...
► Artikel lesen